Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyBiologicalProcessregulation of pro-B cell differentiation

NUDT21 SOS1 SOS2

1.39e-078293GO:2000973
GeneOntologyBiologicalProcessregulation of lymphoid progenitor cell differentiation

NUDT21 SOS1 SOS2

5.45e-0712293GO:1905456
GeneOntologyBiologicalProcesspro-B cell differentiation

NUDT21 SOS1 SOS2

7.08e-0713293GO:0002328
GeneOntologyBiologicalProcesslymphoid progenitor cell differentiation

NUDT21 SOS1 SOS2

6.36e-0626293GO:0002320
GeneOntologyBiologicalProcessregulation of hematopoietic progenitor cell differentiation

NUDT21 SOS1 SOS2

3.64e-0546293GO:1901532
HumanPhenoKeratosis pilaris

ZNF750 KDF1 SOS1 SOS2

1.12e-0637124HP:0032152
DomainRas_G-nucl-exch_fac_CS

SOS1 SOS2

1.95e-0414282IPR019804
DomainRasGEFN

SOS1 SOS2

4.05e-0420282SM00229
DomainRasGEF_N

SOS1 SOS2

4.47e-0421282PF00618
DomainRASGEF_NTER

SOS1 SOS2

4.91e-0422282PS50212
DomainRas-like_Gua-exchang_fac_N

SOS1 SOS2

4.91e-0422282IPR000651
DomainLIPASE_SER

DAGLB LIPF

6.89e-0426282PS00120
DomainRASGEF

SOS1 SOS2

6.89e-0426282PS00720
DomainRASGEF_CAT

SOS1 SOS2

8.58e-0429282PS50009
DomainRasGEF

SOS1 SOS2

9.19e-0430282PF00617
Domain-

SOS1 SOS2

9.19e-04302821.10.840.10
DomainRas_GEF_dom

SOS1 SOS2

9.19e-0430282IPR023578
DomainRASGEF_cat_dom

SOS1 SOS2

9.19e-0430282IPR001895
DomainRasGEF

SOS1 SOS2

9.19e-0430282SM00147
DomainGDS_CDC24_CS

SOS1 SOS2

1.55e-0339282IPR001331
DomainHistone

SOS1 SOS2

3.17e-0356282PF00125
DomainHistone_H2A/H2B/H3

SOS1 SOS2

3.17e-0356282IPR007125
DomainDH_1

SOS1 SOS2

4.00e-0363282PS00741
DomainRhoGEF

SOS1 SOS2

4.64e-0368282SM00325
Domain-

SOS1 SOS2

4.78e-03692821.10.20.10
DomainDH_2

SOS1 SOS2

4.91e-0370282PS50010
DomainRhoGEF

SOS1 SOS2

4.91e-0370282PF00621
DomainDH-domain

SOS1 SOS2

5.05e-0371282IPR000219
Domain-

SOS1 SOS2

5.05e-03712821.20.900.10
DomainHistone-fold

SOS1 SOS2

6.84e-0383282IPR009072
PathwayKEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_PATHWAY_ADAPTOR_PROTEINS

SOS1 SOS2

8.55e-0510202M47930
PathwayKEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_RALGDS_SIGNALING_PATHWAY

SOS1 SOS2

1.04e-0411202M47436
PathwayKEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_RASSF1_SIGNALING_PATHWAY

SOS1 SOS2

1.04e-0411202M47432
PathwayREACTOME_INTERLEUKIN_15_SIGNALING

SOS1 SOS2

1.04e-0411202MM15578
PathwayKEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_JNK_SIGNALING_PATHWAY

SOS1 SOS2

1.48e-0413202M47594
PathwayREACTOME_ACTIVATION_OF_RAC1

SOS1 SOS2

1.48e-0413202M6322
PathwayREACTOME_INTERLEUKIN_15_SIGNALING

SOS1 SOS2

1.72e-0414202M27858
PathwayKEGG_MEDICUS_VARIANT_MET_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY

SOS1 SOS2

1.72e-0414202M47488
PathwayKEGG_MEDICUS_VARIANT_BCR_ABL_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY

SOS1 SOS2

1.72e-0414202M47364
PathwayKEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KIT_TO_RAS_ERK_SIGNALING_PATHWAY

SOS1 SOS2

1.72e-0414202M47365
PathwayKEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_ERK_SIGNALING_PATHWAY

SOS1 SOS2

1.72e-0414202M47366
PathwayKEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_PI3K_SIGNALING_PATHWAY

SOS1 SOS2

1.72e-0414202M47390
PathwayKEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_RAS_ERK_SIGNALING_PATHWAY

SOS1 SOS2

1.72e-0414202M47378
PathwayKEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_MET_TO_RAS_ERK_SIGNALING_PATHWAY

SOS1 SOS2

1.99e-0415202M47367
PathwayKEGG_MEDICUS_VARIANT_IGF2_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY

SOS1 SOS2

1.99e-0415202M47485
PathwayKEGG_MEDICUS_REFERENCE_HGF_MET_RAS_ERK_SIGNALING_PATHWAY

SOS1 SOS2

1.99e-0415202M47473
PathwayKEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_ERK_SIGNALING_PATHWAY

SOS1 SOS2

1.99e-0415202M47474
PathwayKEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_PI3K_SIGNALING_PATHWAY

SOS1 SOS2

1.99e-0415202M47475
PathwayKEGG_MEDICUS_REFERENCE_TGFA_EGFR_RAS_ERK_SIGNALING_PATHWAY

SOS1 SOS2

1.99e-0415202M47480
PathwayKEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_PI3K_SIGNALING_PATHWAY

SOS1 SOS2

1.99e-0415202M47389
PathwayKEGG_MEDICUS_VARIANT_EGF_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY

SOS1 SOS2

1.99e-0415202M47495
PathwayKEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_RAS_ERK_SIGNALING_PATHWAY

SOS1 SOS2

1.99e-0415202M47375
PathwayKEGG_MEDICUS_REFERENCE_EREG_EGFR_RAS_ERK_SIGNALING_PATHWAY

SOS1 SOS2

1.99e-0415202M47496
PathwayKEGG_MEDICUS_REFERENCE_AREG_EGFR_RAS_ERK_SIGNALING_PATHWAY

SOS1 SOS2

1.99e-0415202M47497
PathwayKEGG_MEDICUS_VARIANT_AMPLIFIED_FGFR_TO_RAS_ERK_SIGNALING_PATHWAY

SOS1 SOS2

1.99e-0415202M47380
PathwayKEGG_MEDICUS_REFERENCE_CA2_PYK2_RAS_ERK_SIGNALING_PATHWAY

SOS1 SOS2

1.99e-0415202M47592
PathwayKEGG_MEDICUS_REFERENCE_KITLG_KIT_RAS_ERK_SIGNALING_PATHWAY

SOS1 SOS2

1.99e-0415202M47472
PathwayKEGG_MEDICUS_PATHOGEN_HBV_HBX_TO_RAS_ERK_SIGNALING_PATHWAY

SOS1 SOS2

1.99e-0415202M47593
PathwayKEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_FGF17_TO_RAS_ERK_SIGNALING_PATHWAY

SOS1 SOS2

1.99e-0415202M47640
PathwayKEGG_MEDICUS_PATHOGEN_HCMV_GB_TO_PDGFR_RAS_ERK_SIGNALING_PATHWAY

SOS1 SOS2

1.99e-0415202M47535
PathwayKEGG_MEDICUS_PATHOGEN_HPV_E5_TO_EGFR_RAS_ERK_SIGNALING_PATHWAY

SOS1 SOS2

1.99e-0415202M47531
PathwayKEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_ERK_SIGNALING_PATHWAY

SOS1 SOS2

2.27e-0416202M47363
PathwayWP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER

SOS1 SOS2

2.27e-0416202M39882
PathwayKEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_FGFR3_TO_RAS_ERK_SIGNALING_PATHWAY

SOS1 SOS2

2.27e-0416202M47373
PathwayKEGG_MEDICUS_REFERENCE_IGF_IGF1R_RAS_ERK_SIGNALING_PATHWAY

SOS1 SOS2

2.27e-0416202M47483
PathwayKEGG_MEDICUS_REFERENCE_EGF_ERBB2_RAS_ERK_SIGNALING_PATHWAY

SOS1 SOS2

2.27e-0416202M47381
PathwayKEGG_MEDICUS_REFERENCE_P4_PR_RAS_ERK_SIGNALING_PATHWAY

SOS1 SOS2

2.27e-0416202M47804
PathwayKEGG_MEDICUS_REFERENCE_PDGF_PDGFR_RAS_ERK_SIGNALING_PATHWAY

SOS1 SOS2

2.57e-0417202M47376
PathwayKEGG_DORSO_VENTRAL_AXIS_FORMATION

SOS1 SOS2

5.18e-0424202M11190
PathwaySIG_IL4RECEPTOR_IN_B_LYPHOCYTES

SOS1 SOS2

6.57e-0427202M1718
PathwayPID_RAS_PATHWAY

SOS1 SOS2

8.12e-0430202M269
PathwayWP_MAPK_CASCADE

SOS1 SOS2

9.83e-0433202M39594
PathwayREACTOME_INTERLEUKIN_2_FAMILY_SIGNALING

SOS1 SOS2

1.11e-0335202MM15144
PathwayKEGG_MEDICUS_REFERENCE_FGF_FGFR_RAS_ERK_SIGNALING_PATHWAY

SOS1 SOS2

1.11e-0335202M47379
PathwayREACTOME_INTERLEUKIN_2_FAMILY_SIGNALING

SOS1 SOS2

1.75e-0344202M1012
PathwayWP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY

SOS1 SOS2

1.91e-0346202M39828
PathwaySIG_BCR_SIGNALING_PATHWAY

SOS1 SOS2

1.91e-0346202M8626
PathwayREACTOME_RAC1_GTPASE_CYCLE

SOS1 WIPF3 SOS2

2.12e-03184203M41809
PathwaySIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES

SOS1 SOS2

2.34e-0351202M7955
PathwayKEGG_ENDOMETRIAL_CANCER

SOS1 SOS2

2.43e-0352202M19877
PathwayREACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK

SOS1 SOS2

2.43e-0352202MM14743
PathwayKEGG_NON_SMALL_CELL_LUNG_CANCER

SOS1 SOS2

2.62e-0354202M19818
PathwayKEGG_ACUTE_MYELOID_LEUKEMIA

SOS1 SOS2

2.91e-0357202M19888
PathwayWP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA

SOS1 SOS2

3.12e-0359202M39750
PathwayREACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK

SOS1 SOS2

3.12e-0359202M11215
PathwayWP_ENDOMETRIAL_CANCER

SOS1 SOS2

3.55e-0363202M39623
PathwayKEGG_GLIOMA

SOS1 SOS2

3.77e-0365202M1835
PathwaySIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES

SOS1 SOS2

4.00e-0367202M295
PathwayWP_ACUTE_MYELOID_LEUKEMIA

SOS1 SOS2

4.12e-0368202M48322
PathwayWP_MELANOMA

SOS1 SOS2

4.12e-0368202M39811
PathwayREACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE

SOS1 SOS2

4.36e-0370202MM14824
PathwayKEGG_RENAL_CELL_CARCINOMA

SOS1 SOS2

4.36e-0370202M13266
PathwayWP_NONSMALL_CELL_LUNG_CANCER

SOS1 SOS2

4.61e-0372202M39738
PathwayKEGG_CHRONIC_MYELOID_LEUKEMIA

SOS1 SOS2

4.73e-0373202M321
PathwayKEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY

SOS1 SOS2

4.99e-0375202M5436
PathwayREACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE

SOS1 SOS2

5.12e-0376202M19832
PathwayREACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS

SOS1 SOS2

5.25e-0377202MM15044
PathwayKEGG_FC_EPSILON_RI_SIGNALING_PATHWAY

SOS1 SOS2

5.52e-0379202M11816
PathwayREACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS

SOS1 SOS2

5.66e-0380202M800
PathwayWP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE

SOS1 SOS2

6.22e-0384202M39839
PathwayREACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING

SOS1 SOS2

6.36e-0385202MM14746
Pubmed

SOS2 Comes to the Fore: Differential Functionalities in Physiology and Pathology.

SOS1 SOS2

7.19e-07230234205562
Pubmed

The Ras-specific exchange factors mouse Sos1 (mSos1) and mSos2 are regulated differently: mSos2 contains ubiquitination signals absent in mSos1.

SOS1 SOS2

7.19e-0723029372945
Pubmed

A homologue of the Drosophila Son of sevenless gene maps to mouse chromosome 17.

SOS1 SOS2

7.19e-0723028307589
Pubmed

Critical Requirement of SOS1 for Development of BCR/ABL-Driven Chronic Myelogenous Leukemia.

SOS1 SOS2

7.19e-07230236010887
Pubmed

Chromosomal localization of two genes encoding human ras exchange factors: SOS1 maps to the 2p22-->p16 region and SOS2 to the 14q21-->q22 region of the human genome.

SOS1 SOS2

7.19e-0723028275713
Pubmed

Identification of murine homologues of the Drosophila son of sevenless gene: potential activators of ras.

SOS1 SOS2

7.19e-0723021631150
Pubmed

Absence of both Sos-1 and Sos-2 in peripheral CD4(+) T cells leads to PI3K pathway activation and defects in migration.

SOS1 SOS2

7.19e-07230225973715
Pubmed

Differential Role of the RasGEFs Sos1 and Sos2 in Mouse Skin Homeostasis and Carcinogenesis.

SOS1 SOS2

2.16e-06330229844066
Pubmed

Deconstructing Ras signaling in the thymus.

SOS1 SOS2

2.16e-06330222586275
Pubmed

Functional redundancy of Sos1 and Sos2 for lymphopoiesis and organismal homeostasis and survival.

SOS1 SOS2

2.16e-06330224043312
Pubmed

Disassembly of Son-of-sevenless proteins from Grb2 during p21ras desensitization by insulin.

SOS1 SOS2

2.16e-0633027829473
Pubmed

Differential interactions of human Sos1 and Sos2 with Grb2.

SOS1 SOS2

2.16e-0633027629138
Pubmed

Structural evidence for feedback activation by Ras.GTP of the Ras-specific nucleotide exchange factor SOS.

SOS1 SOS2

2.16e-06330212628188
Pubmed

A new member of the amphiphysin family connecting endocytosis and signal transduction pathways.

SOS1 SOS2

4.31e-0643029182529
Pubmed

Alternative ZAP70-p38 signals prime a classical p38 pathway through LAT and SOS to support regulatory T cell differentiation.

SOS1 SOS2

4.31e-06430231337738
Pubmed

Engagement of the T lymphocyte antigen receptor regulates association of son-of-sevenless homologues with the SH3 domain of phospholipase Cgamma1.

SOS1 SOS2

4.31e-06430210940929
Pubmed

A phospholipase C-γ1-independent, RasGRP1-ERK-dependent pathway drives lymphoproliferative disease in linker for activation of T cells-Y136F mutant mice.

SOS1 SOS2

7.18e-06530223209318
Pubmed

Mutation in Sos1 dominantly enhances a weak allele of the EGFR, demonstrating a requirement for Sos1 in EGFR signaling and development.

SOS1 SOS2

7.18e-0653029030684
Pubmed

The Sos1 and Sos2 Ras-specific exchange factors: differences in placental expression and signaling properties.

SOS1 SOS2

1.08e-05630210675333
Pubmed

Vav1 transduces T cell receptor signals to the activation of the Ras/ERK pathway via LAT, Sos, and RasGRP1.

SOS1 SOS2

1.08e-05630214764585
Pubmed

Mammalian homologues of the Drosophila Son of sevenless gene map to murine chromosomes 17 and 12 and to human chromosomes 2 and 14, respectively.

SOS1 SOS2

1.51e-0573028276400
Pubmed

Erythropoietin receptor Y479 couples to ERK1/2 activation via recruitment of phospholipase Cgamma.

SOS1 SOS2

1.51e-05730215953601
Pubmed

Human epidermal growth factor receptor 2 status modulates subcellular localization of and interaction with estrogen receptor alpha in breast cancer cells.

SOS1 SOS2

1.51e-05730215173068
Pubmed

Frontline Science: TNF-α and GM-CSF1 priming augments the role of SOS1/2 in driving activation of Ras, PI3K-γ, and neutrophil proinflammatory responses.

SOS1 SOS2

1.51e-05730230720883
Pubmed

Interaction domains of Sos1/Grb2 are finely tuned for cooperative control of embryonic stem cell fate.

SOS1 SOS2

2.01e-05830223452850
Pubmed

Germline gain-of-function mutations in SOS1 cause Noonan syndrome.

SOS1 SOS2

2.01e-05830217143285
Pubmed

MADD, a splice variant of IG20, is indispensable for MAPK activation and protection against apoptosis upon tumor necrosis factor-alpha treatment.

SOS1 SOS2

2.58e-05930219289468
Pubmed

B cell antigen receptor signaling induces the formation of complexes containing the Crk adapter proteins.

SOS1 SOS2

2.58e-0593028943292
Pubmed

A novel proteomic screen for peptide-protein interactions.

SOS1 SOS2

2.58e-05930214679214
Pubmed

Homeobox genes and connective tissue patterning.

SOS1 SOS2

3.94e-05113027720577
Pubmed

Local phosphatidylinositol 3,4,5-trisphosphate accumulation recruits Vav2 and Vav3 to activate Rac1/Cdc42 and initiate neurite outgrowth in nerve growth factor-stimulated PC12 cells.

SOS1 SOS2

4.72e-051230215728722
Pubmed

Noonan Syndrome

SOS1 SOS2

7.50e-051530220301303
Pubmed

Selected reaction monitoring mass spectrometry reveals the dynamics of signaling through the GRB2 adaptor.

SOS1 WIPF3 SOS2

9.66e-0510330321706016
Pubmed

Epidermal growth factor receptor phosphorylation sites Ser991 and Tyr998 are implicated in the regulation of receptor endocytosis and phosphorylations at Ser1039 and Thr1041.

SOS1 SOS2

1.09e-041830219531499
Pubmed

Targeting of EGFR by a combination of antibodies mediates unconventional EGFR trafficking and degradation.

SOS1 SOS2

1.22e-041930231959764
Pubmed

Quantitative proteomics reveals that long non-coding RNA MALAT1 interacts with DBC1 to regulate p53 acetylation.

MRPL38 CLPX STRBP

1.88e-0412930328973437
Pubmed

Human Sos1: a guanine nucleotide exchange factor for Ras that binds to GRB2.

SOS1 SOS2

2.13e-04253028493579
Pubmed

The Eyes Absent family members EYA4 and EYA1 promote PLK1 activation and successful mitosis through tyrosine dephosphorylation.

FBRSL1 NUDT21 CNOT4

3.05e-0415230338360978
Pubmed

The layered structure of human mitochondrial DNA nucleoids.

CLPX TOP1MT

3.51e-043230218063578
Pubmed

Tandem immunoprecipitation of phosphotyrosine-mass spectrometry (TIPY-MS) indicates C19ORF19 becomes tyrosine-phosphorylated and associated with activated epidermal growth factor receptor.

SOS1 SOS2

3.74e-043330218271526
Pubmed

Mutation of ARHGAP9 in patients with coronary spastic angina.

SOS1 SOS2

4.96e-043830219911011
Pubmed

Activation of Rac GTPase by p75 is necessary for c-jun N-terminal kinase-mediated apoptosis.

SOS1 SOS2

4.96e-043830211756498
Pubmed

p32/gC1qR is indispensable for fetal development and mitochondrial translation: importance of its RNA-binding ability.

MRPL38 CLPX

5.78e-044130222904065
Pubmed

The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.

FBRSL1 NUDT21 STRBP CNOT4 ALG13

5.85e-0480730522681889
Pubmed

NRAGE, a p75 neurotrophin receptor-interacting protein, induces caspase activation and cell death through a JNK-dependent mitochondrial pathway.

SOS1 SOS2

6.35e-044330212376548
GeneFamilyLipases|Arylacetamide deacetylase family

DAGLB LIPF

2.39e-0422192464
GeneFamilyGlycosyltransferase family 6|Blood group antigens

XG SLC4A1

6.82e-0437192454
GeneFamilyPleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing

SOS1 SOS2

2.16e-0366192722
GeneFamilyPleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing

SOS1 SOS2

1.94e-02206192682
ToppCellIIF-Other-RBC|IIF / Disease, Lineage and Cell Type

ASCC2 XG CLIC2 SLC4A1

7.13e-06186304db3c3fc2045c657b300b640bf228640c30782509
ToppCell356C-Fibroblasts-Fibroblast-H|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)

ZNF597 DAGLB TOP1MT

1.41e-0415130322afd8201eff8471da3456be065f2790de5e4bfe
ToppCell356C-Fibroblasts-Fibroblast-H-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)

ZNF597 DAGLB TOP1MT

1.41e-041513032dc132895609e4efe17954e31f53d9c1ccf256ef
ToppCellTransverse-Dendritic_cell-cDC1|Dendritic_cell / Region, Cell class and subclass

CLPX TOP1MT CLIC2

1.41e-041513036870f3b5d2bfad849c3203658b5f28f0ae181295
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Dendritic-conventional_dendritic_cell-DC_c1-CLEC9A|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)

ZNF750 TOP1MT CLIC2

1.58e-0415730319c0599a669803c4db1f174de1ce755e562a50a3
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

ZNF750 SLC4A1 WIPF3

1.61e-041583035775246e192629058ed89fb56031bdf4cbb9c15c
ToppCellwk_20-22-Hematologic-Myeloid-GMP|wk_20-22 / Celltypes from embryonic and fetal-stage human lung

DAGLB TOP1MT TET3

1.86e-04166303d96e88e73a40205f32cebd7e54ca1ff09ee1e7e8
ToppCellfacs-Lung-nan-3m-Epithelial-Club_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ASCC2 ZNF750 KDF1

2.25e-04177303b37d821f4f3204daf7c568ac17a0af0ba97273d6
ToppCellfacs-Lung-nan-3m-Epithelial-club_cell_of_bronchiole|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ASCC2 ZNF750 KDF1

2.25e-04177303e5070934c674a46e070b0d52b9a374516bf6aea1
ToppCellCOVID-19_Moderate-RBC|World / disease group, cell group and cell class

ASCC2 XG SLC4A1

2.32e-04179303932fa98c0981ef8ef1e4945cdd4ae8c6c0858251
ToppCellMultiple_Sclerosis-Other-RBC|Multiple_Sclerosis / Disease, Lineage and Cell Type

XG CLIC2 SLC4A1

2.32e-0417930315763dc59ee6186416e203ffbb450ae4608eba59
ToppCell5'-GW_trimst-2-LymphNode-Hematopoietic-Red_blood_cells|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ASCC2 CLIC2 SLC4A1

2.40e-04181303577bf37a6594fad01251d2c66d8ccda8e949b6cf
ToppCell5'-GW_trimst-2-LymphNode-Hematopoietic-Red_blood_cells-RBC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ASCC2 CLIC2 SLC4A1

2.40e-04181303f5dc7a650afe8837cb424981e50ad2c8b18c7c32
ToppCellCOVID-19_Moderate-RBC|COVID-19_Moderate / disease group, cell group and cell class

ASCC2 XG SLC4A1

2.48e-041833030dc337cd3f4f7964b0a268139c7ddc0f58b6a279
ToppCellMS-IIF-Others-RBC|IIF / Disease, condition lineage and cell class

ASCC2 CLIC2 SLC4A1

2.52e-04184303578bde79b464ed12dd9a53dd8e2839e156220a60
ToppCellCOVID-19_Severe-RBC|COVID-19_Severe / disease group, cell group and cell class

ASCC2 CLIC2 SLC4A1

2.52e-04184303bb58244194ffb5558fbe85c5f856888210dcb1e8
ToppCellCOVID-19_Severe-Hematopoietic_R|COVID-19_Severe / Disease group, lineage and cell class

ASCC2 CLIC2 SLC4A1

2.56e-0418530330f064ab7c3890e6f419a845276b145112e78f52
ToppCellPBMC-Severe-Hematopoietic-RBC-RBC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

ASCC2 CLIC2 SLC4A1

2.56e-0418530317542ccd52a821c9e99b1a7469e80502e764b3fd
ToppCellPBMC-Severe-Hematopoietic-RBC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

ASCC2 CLIC2 SLC4A1

2.56e-04185303d685a5a2e525db2eba449cfa1e5cd54eb36162a8
ToppCellPBMC-Severe-Hematopoietic-RBC-RBC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

ASCC2 CLIC2 SLC4A1

2.56e-04185303f3b1907c3b6f930bc161f46efce5e143babab507
ToppCellPBMC-Severe-Hematopoietic-RBC-RBC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

ASCC2 CLIC2 SLC4A1

2.56e-0418530344ce50cb99df8ffc50eba311adcf688477618659
ToppCellPBMC-Severe-Hematopoietic-RBC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

ASCC2 CLIC2 SLC4A1

2.56e-041853035d8d6fd7800f76ee3aa5cef95241d8e6d7e8db04
ToppCellCOVID-19_Severe-Hematopoietic_R-RBC|COVID-19_Severe / Disease group, lineage and cell class

ASCC2 CLIC2 SLC4A1

2.56e-041853033ed6090b822c6d1d400a421236cddc7511743932
ToppCellPBMC-Severe-Hematopoietic-RBC-RBC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

ASCC2 CLIC2 SLC4A1

2.56e-04185303100b5afdf3c6ab07ffc493f7883f5a7b31c59184
ToppCellSmart-seq2-blood_(Smart-seq2)-hematologic-erythrocytic|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

ASCC2 CLIC2 SLC4A1

2.64e-0418730313023661c26aaf9e42262a4ff91f2fb26e8a3eaf
ToppCellSmart-seq2-blood_(Smart-seq2)-hematologic-erythrocytic-erythrocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

ASCC2 CLIC2 SLC4A1

2.64e-04187303c4ba9dfedbcf0357a8627af03f4fe1770e985a03
ToppCell10x_3'_v3-blood_(10x_3'_v3)-hematologic-erythrocytic-erythrocyte|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

ASCC2 CLIC2 SLC4A1

2.68e-04188303da211e7fb62fff176aa9c39061aef9ab0af6079e
ToppCell10x_3'_v3-blood_(10x_3'_v3)-hematologic-erythrocytic|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

ASCC2 CLIC2 SLC4A1

2.68e-041883033467149de45b47a5015486ef94bec070e9c3ffc2
ToppCell10x_3'_v3-blood_(10x_3'_v3)-hematologic|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

ASCC2 CLIC2 SLC4A1

2.68e-041883033c6c0eaadc474ebb218ae349b787c410f66177ab
ToppCellsevere_COVID-19-RBC|severe_COVID-19 / disease group, cell group and cell class (v2)

ASCC2 CLIC2 SLC4A1

2.77e-041903033a5723c2daf58c1932edd70910db4b8b30f63f42
ToppCell10x_3'_v3-bone_marrow_(10x_3'_v3)-hematologic-erythrocytic-erythrocyte|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

ASCC2 CLIC2 SLC4A1

2.90e-04193303305e15ee467826ee08b2617c69f250ad39c11b19
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Degenerative_Cortical_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

ZNF750 COPRS SLC4A1

2.90e-041933030be0c4ca363611c04402b13929bb6d3ff68b9ec7
ToppCell10x_3'_v3-bone_marrow_(10x_3'_v3)-hematologic-erythrocytic|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

ASCC2 CLIC2 SLC4A1

2.90e-04193303dd376664906caccc9c2065f8e7a364509e18a5cc
ToppCellMegakaryocytic-erythropoietic-Erythro-cells-Erythrocyte|Megakaryocytic-erythropoietic / Lineage, cell class and subclass

ASCC2 CLIC2 SLC4A1

2.94e-04194303f0ababe8daa57f6827a3e2e72c884d9e8b2687a3
ToppCell10x3'2.3-week_17-19-Hematopoietic-erythroid-late_erythroid|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

ASCC2 CLIC2 SLC4A1

2.94e-0419430323b06707d21306b4483d64cb350b86aef352ce38
ToppCellMegakaryocytic-erythropoietic-Erythro-cells|Megakaryocytic-erythropoietic / Lineage, cell class and subclass

ASCC2 CLIC2 SLC4A1

3.03e-04196303092caba6726d1acd409a8be335100764d0724e64
ToppCell10x5'v1-week_14-16-Hematopoietic-erythroid-late_erythroid|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

ASCC2 CLIC2 SLC4A1

3.17e-041993035b2b5327813b44c334f81424139e6d719343966d
ToppCellMS-Multiple_Sclerosis-Others-RBC|Multiple_Sclerosis / Disease, condition lineage and cell class

ASCC2 CLIC2 SLC4A1

3.17e-04199303b9e7549f67bc33284bacf9a160b3916651659809
ToppCellCOVID-19-COVID-19_Severe-Others-RBC|COVID-19_Severe / Disease, condition lineage and cell class

ASCC2 CLIC2 SLC4A1

3.22e-04200303308f74e7e13ecc6d133c219c42cc8895a96644c8
DrugLumicolchicine gamma [6901-14-0]; Down 200; 10uM; HL60; HT_HG-U133A

GTDC1 CNOT4 ALG13 SOS1 SOS2

5.51e-061973051317_DN
DiseaseNoonan syndrome-like disorder with loose anagen hair

SOS1 SOS2

1.69e-0419302C1843181
DiseaseNoonan-Like Syndrome With Loose Anagen Hair

SOS1 SOS2

1.69e-0419302C3501846
DiseaseCostello syndrome (disorder)

SOS1 SOS2

1.69e-0419302C0587248
DiseaseCardio-facio-cutaneous syndrome

SOS1 SOS2

1.69e-0419302C1275081
DiseaseLEOPARD Syndrome

SOS1 SOS2

2.28e-0422302C0175704
DiseaseNoonan Syndrome

SOS1 SOS2

2.72e-0424302C0028326
DiseaseAdenocarcinoma of lung (disorder)

NUDT21 STRBP SOS1

1.18e-03206303C0152013
Diseaseurate measurement

FBRSL1 KDF1 NUDT21 SLC4A1 SOS2

1.93e-03895305EFO_0004531

Protein segments in the cluster

PeptideGeneStartEntry
PPFDKYAPKLDSPYF

FBRSL1

476

Q9HCM7
PFPYKVLKALDPEIY

ALG13

451

Q9NP73
PPPPKKIYNYLDKYV

CLPX

166

O76031
LLFKPPKYHPDVPYV

SLC4A1

811

P02730
YFVLYKPPPKDNIPA

ASCC2

36

Q9H1I8
FLFPQYPIKPYHLKG

ANKRD36C

21

Q5JPF3
YEPTIYYPKRPNKPL

NAXE

136

Q8NCW5
FKEHLIPHSYYPLKP

FSIP2

4096

Q5CZC0
PKLPNLIYHKEIPFY

LIPF

356

P07098
YPHYKPPEKCPSIIL

PCYOX1

436

Q9UHG3
LPYEPYKALHGPLPL

MACIR

141

Q96GV9
HPPPLIPYYSKMVFE

COPRS

161

Q9NQ92
KYPPLYPPGRIIHLQ

DAGLB

586

Q8NCG7
LSYALKPPPVPKHEY

DEFB124

56

Q8NES8
PQYPYIPAHITKPKE

NUDT21

156

O43809
YPLCPKDLVYPEIFP

GTDC1

386

Q4AE62
PPRYPHLSPKYKESF

CLIC2

96

O15247
KFHPYPPSVLPDYHL

SPATA48

66

A4D263
NSDIYPKPKPPYYPQ

XG

41

P55808
PPKTYKRELSHPPLY

SOS2

1306

Q07890
LPVMKFPTYPVPHYS

STRBP

656

Q96SI9
FPPPDEYKPCQKIYP

WIPF3

431

A6NGB9
YPDVKLKGIPVYPYP

KDF1

161

Q8NAX2
PKPLPRFPKKYSYPL

SOS1

1021

Q07889
CRKPYPEDPAVYKPL

CNOT4

56

O95628
VYGPHQYPEKVIPKF

TGDS

196

O95455
KPHYIPRPPGKPFKY

ZNF750

11

Q32MQ0
VFEFVRPPPYHPKQK

MRPL38

341

Q96DV4
LEHKGPYFAPPYEPL

TOP1MT

56

Q969P6
YPGPKEYLLPKAPLL

TET3

1361

O43151
ALEKYPIAAPLVPYP

ZNF597

76

Q96LX8